Medtronic had four patents in cybersecurity during Q1 2024. Medtronic Plc’s patents in Q1 2024 focus on facilitating trusted pairing between implantable medical devices and external devices, as well as on a medical system that includes a device for detecting and tracking the presence of compounds in a patient using fluorescent markers. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Medtronic Plc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Medtronic grant share with cybersecurity as a theme is 25% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Facilitating trusted pairing of an implantable device and an external device (Patent ID: US20240075305A1)

The patent filed by Medtronic Plc describes systems and methods for establishing a trusted pairing between an implantable medical device (IMD) and an external device. The IMD includes components such as a communication component to initiate a telemetry connection with an external device and a validation component to restrict the connection based on validation information received from the external device. The validation information is not part of the telemetry protocol, ensuring secure and authorized connections between devices. The patent also details the negotiation of encryption keys, association of identifiers, and transmission of physiological data between the devices.

The claims in the patent outline the specific functionalities and processes involved in the trusted pairing between the IMD and external device. These include negotiating encryption keys, associating identifiers with authorized devices, transmitting physiological data, and handling validation information. The patent covers scenarios where validation can be performed by a remote server, application on the second device, or unique out-of-band signals. It also addresses unauthorized connection attempts, tracking failures to provide validation information, and the authorization of future connections based on successful validation. Overall, the patent focuses on ensuring secure and validated communication between IMDs and external devices, enhancing patient safety and data privacy in medical settings.

To know more about GlobalData’s detailed insights on Medtronic, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.